Clinical Trials · NCT03663582
Study of Teduglutide in Japanese Participants With Short Bowel Syndrome
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Shire
- Enrollment
- 7
- Start date
- Jul 2018
- Locations
- 5 sites, Japan
- Primary endpoint
- Change From Baseline in Weekly Parenteral Support (PS) Volume at End of Treatment/Early Termination (EOT/ET)